0001628280-20-014509.txt : 20201015
0001628280-20-014509.hdr.sgml : 20201015
20201015185721
ACCESSION NUMBER: 0001628280-20-014509
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200723
FILED AS OF DATE: 20201015
DATE AS OF CHANGE: 20201015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foley Mark J
CENTRAL INDEX KEY: 0001529196
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 201242376
MAIL ADDRESS:
STREET 1: ZELTIQ AESTHETICS INC.
STREET 2: 4698 WILLOW ROAD SUITE 100
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
wf-form4_160280262897368.xml
FORM 4
X0306
4
2020-07-23
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001529196
Foley Mark J
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BLVD.
NEWARK
CA
94560
1
1
0
0
CEO & President
Common Stock
2020-07-23
4
A
0
264439
A
835670
D
Common Stock
2020-07-23
4
A
0
50913
A
70913
I
See footnote
Common Stock
2020-10-13
4
F
0
66106
27.62
D
769564
D
On July 23, 2020. the Issuer completed acquisition (the "Merger") of Hint, Inc. ("HintMD") pursuant to that certain Agreement and Plan of Merger, dated as of May 18, 2020, by and among the Issuer, HeartMerger Sub, Inc., direct wholly-owned subsidiary of the Issuer, HintMD, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by Mr. Foley and the Foley Family Trust in HintMD were automatically cancelled and converted into the right to receive shares of common stock of the Issuer.
These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.
Represents the number of shares withheld by and surrendered to the Issuer on October 13, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award ("RSA") for 133,332 shares. The RSA vests in three equal annual installments from October 13, 2019, subject to Mr. Foley's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
/s/ Gordon Ho, Attorney-in-Fact
2020-10-15